MYC and neoplasm: PI3K (phosphoinositide-3-kinase)/mTOR inhibitors are initially successful in suppressing tumor growth in animal models of ovarian cancer, but eventually resistance occurs due to the upregulation of the MYC and YAP transcriptional regulators [139].